Analyzing...
Loading company...
No significant concerns identified
Nothing flagged for monitoring
“Services business in Healthcare — Hospitals & Diagnostics.”
₹1,262 Cr service revenue.
Employee costs at 17.0% of revenue — primary cost driver.
“total income stood at INR 365.”
“beginning next quarter, you will see a much higher depreciation load than you have seen so far and should also expect an EBITDA drag on the consolidated numbers for around the next”
“mature asset alphab's should grow in line with inflation and the newer hospitals should grow a little faster in the earlier phases.”
| KPI | Company | Sector Median |
|---|---|---|
| ROE | 13.0%▲ | 7.9% |
| ROCE | 15.4%▲ | 11.3% |
| Net Margin | 12.8%▲ | 9.3% |
| EBITDA Margin | 24.8%▲ | 21.9% |
| Debt To Equity | 0.23x▲ | 0.16x |
| Employee Cost Ratio | 17.00x | - |
Historical valuation data not available.
| (₹ Cr) | TTM | FY2025 | FY2024 |
|---|---|---|---|
| Revenue | ₹1,433 Cr +13.6% | ₹1,262 Cr +18.0% | ₹1,070 Cr |
| Other Income | ₹40 Cr +40.5% | ₹29 Cr +10.4% | ₹26 Cr |
| Total Income | ₹1,474 Cr +14.2% | ₹1,290 Cr +17.8% | ₹1,095 Cr |
| COGS | ₹272 Cr +18.3% | ₹230 Cr +21.5% | ₹189 Cr |
| ₹1,213 Cr +17.4% | ₹1,033 Cr +14.7% | ₹900 Cr | |
| Profit Before Tax | ₹255 Cr -1.1% | ₹258 Cr +31.9% | ₹195 Cr |
| Exceptional Items | (₹6 Cr) | ₹0.00 Cr | ₹0.00 Cr |
| ₹66 Cr +2.9% | ₹64 Cr +241.4% | ₹19 Cr | |
| Net Profit | ₹189 Cr -2.5% | ₹194 Cr +9.6% | ₹177 Cr |
| Profit (Owners) | ₹189 Cr -2.4% | ₹193 Cr +9.4% | ₹177 Cr |
| Minority Interest | ₹0.12 Cr -60.1% | ₹0.30 Cr | ₹0.00 Cr |
| Other Comprehensive Income | (₹1 Cr) 0.0% | (₹1 Cr) ↓ Decline | ₹1 Cr |
| EPS | ₹28.77 | ₹29.47 | ₹26.94 |
| Diluted Shares | ₹7 Cr | ₹7 Cr | ₹7 Cr |
No related party data available for this company.
This section will be populated when data becomes available.
Disclaimer · The Stock Filter is an information platform, not a SEBI-registered investment adviser. All data, scores, and narratives are generated from public filings and AI analysis — they do not constitute investment advice, recommendations, or endorsements. Always consult a qualified financial adviser before making investment decisions. Past performance does not guarantee future results.
Q4 & FY 26 Earnings Conference Call Transcript
Audio Link of Analyst /Investor Conference call for Q4 & FY 26
Jupiter Life Line Hospitals Limited has informed the Exchange regarding Resignation of Mr Sivasis Sen as Chief Financial Officer of the company w.e.f. May 31, 2026.
The Company has received a letter from Mumbai Metropolitan Region Development Authority (MMRDA) conveying the acceptance of its tender for allotment of land on lease basis
Jupiter Life Line Hospitals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Jupiter Life Line Hospitals Limited has informed the Exchange about Schedule of meet
Jupiter Life Line Hospitals Limited has informed the Exchange about Transcript
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure requirements) Regulations 2015.
Jupiter Life Line Hospitals Limited has informed the Exchange about Link of Recording
Jupiter Life Line Hospitals Limited has informed the Exchange about Copy of Newspaper Publication
Jupiter Life Line Hospitals Limited has informed the Exchange about Investor Presentation
Jupiter Life Line Hospitals Limited has informed the Exchange about Investor Presentation
Commencement of operations at Jupiter Hospital, Dombivli, Mumbai Metropolitan Region.
Outcome of Board Meeting dated January 30, 2026.
Intimation of Earnings Conference Call - Q3 & 9M FY 26